Objective The prevalence of symptomatic coeliac disease in Norway is 1:675.
Coeliac disease has previously been reported in presumably healthy people.
Our aim was to determine the prevalence of latent coeliac disease in appar
ently healthy (i.e. asymptomatic) Norwegian individuals.
Methods Blood donor sera were tested for gluten antibodies (IgA, IgG). Posi
tive samples (IgA AGA > 0.35, IgG AGA > 0.90) were further tested for endom
ysium antibodies (IgA EMA). EMA positive individuals were offered gastroent
erological investigation.
Results Of 2096 sera, 83 fulfilled the criteria for EMA testing (M/F = 55/2
8). Eight individuals were EMA positive. On biopsy, seven out of eight had
villous atrophy (six subtotal, one partial). None of the patients had signi
ficant symptoms. Biochemical data showed iron deficiency (two), hypocalcaem
ia tone), and low serum zinc (five). All patients were treated with a glute
n-free diet and followed up.
Conclusion The study indicates a prevalence of 1:340 among asymptomatic and
presumably healthy people. This is in keeping with studies from other coun
tries. Lack of symptoms does not exclude secondary deficiency conditions. (
C) 1999 Lippincott Williams & Wilkins.